Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Response to Crockford et al.: Healthcare utilization and mortality after overdose prevention site closure: A linked cohort analysis using segmented difference-in-differences time series.
Journal: Addiction (Abingdon, England)
Published: April 22, 2026
Reframing Buprenorphine as a Pharmacologic Modifier of Opioid-Induced Respiratory Depression in the Fentanyl Era.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 10, 2026
Clozapine Therapy With or Without Antipsychotic Augmentation: A Retrospective Evaluation of Prescribing Practices in a Canadian Provincial Residential Treatment Centre for Concurrent Disorders: Traitement par la clozapine avec ou sans intensification à l'aide d'antipsychotiques : évaluation rétrospective des pratiques de prescription dans un centre de traitement résidentiel provincial canadien pour les troubles concomitants.
Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie
Published: December 19, 2025
Healthcare utilization and mortality after overdose prevention site closure: A linked cohort analysis using segmented difference-in-differences time series.
Journal: Addiction (Abingdon, England)
Published: September 11, 2025
Direct Induction of Buprenorphine Extended-Release: A Case Report.
Journal: Journal of addiction medicine
Published: January 09, 2025
24-Hour Induction of Transdermal Buprenorphine to Buprenorphine Extended-Release.
Journal: Journal of psychoactive drugs
Published: November 19, 2024
Case series: Symptom-inhibited fentanyl induction (SIFI) onto treatment-dose opioid agonist therapy in a community setting.
Journal: The American journal on addictions
Published: October 29, 2024
What Psychiatrists Should Know About Prescribed Safer Opioid Supply.
Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie
Published: October 16, 2024
Rapid intravenous symptom-inhibiting fentanyl induction (SIFI) to optimize rotation onto oral opioid agonist therapy among individuals who use unregulated fentanyl: protocol for an open-label, single arm clinical trial.
Journal: Addiction science & clinical practice
Published: October 07, 2024
Substance-Related Withdrawal Catatonia in Co-occurring Disorders: Lessons Learned From Two Case Reports.
Journal: Journal of clinical psychopharmacology
Published: August 22, 2024
Capacity Assessments and the Assessment of Voluntariness in the Context of MAiD Legislation: The Role and Responsibility of Psychiatrists.
Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie
Published: January 19, 2024
Last Updated: 09/26/2026